CL2004001607A1 - Uso de gabaxafol para preparar un medicamento util en el tratamiento de la depresion. - Google Patents

Uso de gabaxafol para preparar un medicamento util en el tratamiento de la depresion.

Info

Publication number
CL2004001607A1
CL2004001607A1 CL200401607A CL2004001607A CL2004001607A1 CL 2004001607 A1 CL2004001607 A1 CL 2004001607A1 CL 200401607 A CL200401607 A CL 200401607A CL 2004001607 A CL2004001607 A CL 2004001607A CL 2004001607 A1 CL2004001607 A1 CL 2004001607A1
Authority
CL
Chile
Prior art keywords
gabaxafol
depression
prepare
treatment
medicinal product
Prior art date
Application number
CL200401607A
Other languages
English (en)
Inventor
Connie Ebert Bjarke Sanchez
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58707228&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2004001607(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of CL2004001607A1 publication Critical patent/CL2004001607A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
CL200401607A 2003-06-25 2004-06-24 Uso de gabaxafol para preparar un medicamento util en el tratamiento de la depresion. CL2004001607A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200300956 2003-06-25
DKPA200400016 2004-01-07

Publications (1)

Publication Number Publication Date
CL2004001607A1 true CL2004001607A1 (es) 2005-05-27

Family

ID=58707228

Family Applications (2)

Application Number Title Priority Date Filing Date
CL200401607A CL2004001607A1 (es) 2003-06-25 2004-06-24 Uso de gabaxafol para preparar un medicamento util en el tratamiento de la depresion.
CL2010000166A CL2010000166A1 (es) 2003-06-25 2010-02-25 Uso de gaboxadol para preparar una composicion farmaceutica para ser utilizada en combinacion con un inhibidor de la reabsorcion de serotonina o con cualquier otro compuesto que logre una elevacion en el nivel de serotonina extracelular; y composicion farmaceutica (sol. div. 1607-04).

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL2010000166A CL2010000166A1 (es) 2003-06-25 2010-02-25 Uso de gaboxadol para preparar una composicion farmaceutica para ser utilizada en combinacion con un inhibidor de la reabsorcion de serotonina o con cualquier otro compuesto que logre una elevacion en el nivel de serotonina extracelular; y composicion farmaceutica (sol. div. 1607-04).

Country Status (10)

Country Link
KR (1) KR20060025192A (es)
AR (1) AR047550A1 (es)
CA (2) CA2529805A1 (es)
CL (2) CL2004001607A1 (es)
EA (1) EA200600101A1 (es)
IS (1) IS8138A (es)
ME (2) MEP1908A (es)
NO (1) NO20060229L (es)
RS (1) RS20050911A (es)
TW (1) TW200509918A (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3120856A1 (en) 2018-11-21 2020-05-28 Certego Therapeutics, Inc. Gaboxadol for reducing risk of suicide and rapid relief of depression
WO2021236876A2 (en) 2020-05-20 2021-11-25 Certego Therapeutics Inc. Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders

Also Published As

Publication number Publication date
IS8138A (is) 2005-11-21
NO20060229L (no) 2006-01-16
CA2529805A1 (en) 2004-12-29
CL2010000166A1 (es) 2010-07-02
TW200509918A (en) 2005-03-16
AR047550A1 (es) 2006-01-25
RS20050911A (en) 2007-08-03
MEP1908A (xx) 2010-02-10
CA2692334A1 (en) 2004-12-29
KR20060025192A (ko) 2006-03-20
EA200600101A1 (ru) 2006-06-30
ME00030B (me) 2010-06-10

Similar Documents

Publication Publication Date Title
CY2013002I1 (el) 8-[3-αμινο-πιπεριδιν-1-υλο]-ξανθινες, παραγωγη αυτων και χρηση τους ως φαρμακων
UY27720A1 (es) Aroilpiridinonas monocíclicas,
CL2004000889A1 (es) COMPUESTOS DERIVADOS DE PIRAZOLO[4,3-d]PIRIMIDINA; COMPUESTOS INTERMEDIARIOS; COMPOSICION FARMACEUTICA; PROCEDIMIENTO DE PREPARACION Y SU USO EN LA PREPARACION DE UN MEDICAMENTO PARA EL TRATAMIENTO DE LA HIPERTENSION.
ES2967961T3 (es) Liposomas útiles en la administración de fármacos
BR0309544A (pt) Preparação farmacêutica contendo oxicodona e naloxona
PL377795A1 (pl) Pirymidyny będące inhibitorami Chk, Pdk i Akt, sposób ich wytwarzania oraz ich zastosowanie jako środków farmaceutycznych
IL185381A0 (en) Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments
ITMI20031570A1 (it) Composizione per uso dietetico, farmaceutico o cosmetico
IS8105A (is) Lyfjablanda sem felur í sér ónæmisbæli til að nota í meðhöndlun á húðsjúkdómum
PT1500654E (pt) Derivados de benzoxazinona, sua preparacao e utilizacao como medicamentos
IS7564A (is) Lyfjablanda með breytta losun
IL183395A0 (en) Meta-substituted thiazolidinones, the production thereof and their use as medicaments
CL2007002619A1 (es) Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion.
ITRM20030204A1 (it) Formulazione dermatologica.
PL394604A1 (pl) Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna
CL2004001068A1 (es) Compuestos derivados de 2,3,4,5-tetrahidrobenzo[f][1,4]oxazepina; procedimientos de preparacion; composicion farmaceutica que los contiene y su uso en la elaboracion de un medicamento util para el tratamiento de la enfermedad de alzheimer.
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
ZA200710146B (en) New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
CL2004001607A1 (es) Uso de gabaxafol para preparar un medicamento util en el tratamiento de la depresion.
IL186851A0 (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
CL2004001603A1 (es) Uso de gabaxadol para preparar un medicamento util para el tratamiento del dolor neuropatico.
ZA200705782B (en) Meta-substituted thiazolidinones, the production thereof and their use as medicaments
ZA200710147B (en) New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
ITPR20040020A1 (it) Attrezzo da palestra per traslare l'appoggio rovesciato.
CL2004000048A1 (es) Uso de compuestos derivados de acetanilida heterosustituido para preparar un medicamento util en el tratamiento del dolor o la fiebre.